Expanding the phenotypic spectrum of FGF12-epilepsy—does prompt precision therapy affect outcomes?

Leo Arkush, Kristina Karandasheva, Frédérique Ouellet, Alissa M. D’Gama, Beth Rosen Sheidley, Nicole S. Y. Liang, Vann Chau, Gregory Costain, Lacey Smith, Anoushka Alwis, Christin Eltze, Annapurna Poduri, Felice D’Arco, Josh Adams, Kristen Lee, Jaspal Singh, Alexander P. Y. Brown, Arjuna Nagendran, Ben Pode-Shakked, Michal Tzadok, Bruria Ben Zeev, Amy McTague

Open source

DOI
10.1038/s41525-026-00581-0
Published
2026-05-25
Container
npj Genomic Medicine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41525-026-00581-0,
  title = {Expanding the phenotypic spectrum of FGF12-epilepsy—does prompt precision therapy affect outcomes?},
  author = {Leo Arkush and Kristina Karandasheva and Frédérique Ouellet and Alissa M. D’Gama and Beth Rosen Sheidley and Nicole S. Y. Liang and Vann Chau and Gregory Costain and Lacey Smith and Anoushka Alwis and Christin Eltze and Annapurna Poduri and Felice D’Arco and Josh Adams and Kristen Lee and Jaspal Singh and Alexander P. Y. Brown and Arjuna Nagendran and Ben Pode-Shakked and Michal Tzadok and Bruria Ben Zeev and Amy McTague},
  year = {2026},
  journal = {npj Genomic Medicine},
  doi = {10.1038/s41525-026-00581-0},
  url = {https://doi.org/10.1038/s41525-026-00581-0}
}

RIS

TY  - JOUR
TI  - Expanding the phenotypic spectrum of FGF12-epilepsy—does prompt precision therapy affect outcomes?
AU  - Leo Arkush
AU  - Kristina Karandasheva
AU  - Frédérique Ouellet
AU  - Alissa M. D’Gama
AU  - Beth Rosen Sheidley
AU  - Nicole S. Y. Liang
AU  - Vann Chau
AU  - Gregory Costain
AU  - Lacey Smith
AU  - Anoushka Alwis
AU  - Christin Eltze
AU  - Annapurna Poduri
AU  - Felice D’Arco
AU  - Josh Adams
AU  - Kristen Lee
AU  - Jaspal Singh
AU  - Alexander P. Y. Brown
AU  - Arjuna Nagendran
AU  - Ben Pode-Shakked
AU  - Michal Tzadok
AU  - Bruria Ben Zeev
AU  - Amy McTague
PY  - 2026
JO  - npj Genomic Medicine
DO  - 10.1038/s41525-026-00581-0
UR  - https://doi.org/10.1038/s41525-026-00581-0
ER  - 

APA

Arkush, L., Karandasheva, K., Ouellet, F., D’Gama, A. M., Sheidley, B. R., Liang, N. S. Y., Chau, V., Costain, G., Smith, L., Alwis, A., Eltze, C., Poduri, A., D’Arco, F., Adams, J., Lee, K., Singh, J., Brown, A. P. Y., Nagendran, A., Pode-Shakked, B., Tzadok, M., Zeev, B. B., & McTague, A. (2026). Expanding the phenotypic spectrum of FGF12-epilepsy—does prompt precision therapy affect outcomes?. npj Genomic Medicine. https://doi.org/10.1038/s41525-026-00581-0

Source records